Federal Panel to Consider Consolidation of Lawsuits Involving da Vinci Surgical Robot Injuries, Pradaxa Bleeding Side Effects, and Fentanyl Patch Complications

Share Article

The U.S. Judicial Panel on Multidistrict Litigation will Convene on July 26, 2012, to Hear Oral Arguments Regarding the Consolidation of Lawsuits Involving da Vinci Surgical Robot Injuries, Pradaxa Bleeding Side Effects, and Complications Caused by Defective Fentanyl Pain Patches.

Image of da Vinci Robot. All motions being considered involve allegations that individuals experienced severe ors fatal injuries due to the da Vinci Surgical Robot, Pradaxa, & fentanyl pain patches.

Image of da Vinci Robot. All motions being considered involve allegations that individuals experienced severe ors fatal injuries due to the da Vinci Surgical Robot, Pradaxa, & fentanyl pain patches.

If you've been severly injured by a da Vinci Surgical Robot, Pradaxa, or Fentanyl Pain Patches get the help you need and deserve! Call Now!1-800-403-6191 or visit www.fightforvictims.com

Attorneys Andres Alonso and David Krangle, founding partners of Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, report that the U.S. Judicial Panel on Multidistrict Litigation (JPML) will meet on Thursday, July 26, 2012, to hear oral arguments regarding the establishment of multidistrict litigations for federal claims involving Pradaxa (dabigitran) lawsuits due to alleged bleeding side effects, da Vinci Surgical Robot lawsuits due to alleged injuries, and fentanyl pain patch lawsuits due to alleged complications caused by defective pain patches. According to a schedule issued by the Panel, oral arguments on these and other matters will commence at 9:30 a.m. at the Carl B. Stokes U.S. Courthouse, Ceremonial Courtroom in Cleveland, Ohio. [jpml.uscourts.gov/sites/jpml/files/Hearing%20Order-7-26-12.pdf]

All of the motions being considered involve allegations that individuals experienced severe and sometimes fatal injuries due to the use of the da Vinci Surgical Robot, the drug Pradaxa, and defective fentanyl pain patches. Multidistrict litigations are established when there exists a large number of claims involving similar allegations or facts. The process is designed to reduce duplicative discovery, eliminate contradictory pretrial rulings from different judges and to serve the convenience of the witnesses, the parties and the courts.

Alonso Krangle LLP offers free lawsuit evaluations to victims of da Vinci Surgical Robot injuries, Pradaxa side effects, or defective fentanyl pain patches. To discuss a potential personal injury lawsuit with one of the experienced and compassionate product liability lawyers Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

da Vinci Surgical Robot Litigation Products Liability Litigation (MDL 2381)

Currently four federal complaints alleging injuries due to use of the da Vinci Surgical Robot are pending in four U.S. District Courts. According to the Panel’s Hearing Schedule, Plaintiffs have motioned for consolidation in the Southern District of Mississippi or, alternatively, the Northern District of California.

Manufactured by Intuitive Surgical, the da Vinci Surgical Robot is a robotic surgical system that features four remote controlled arms and a camera, allowing surgeons to operate through a small incision with a joystick-like control. Lawsuits allege that use of the da Vinci Surgical Robot caused serious and sometimes fatal injuries, including internal burns, tears and other complications. Among other things, Plaintiffs allege that Intuitive sold the robotic surgery system without ensuring proper training and instructions for surgeons, and without providing adequate warnings for consumers about the risk of problems that may develop during surgical procedures that employ the da Vinci Surgical Robot.

Pradaxa Products Liability Litigation (MDL 2385)

According to the Hearing Schedule, more than 20 lawsuits involving allegations that use of the drug Pradaxa led to serious, and sometimes fatal incidents of internal bleeding are pending in a dozen federal districts throughout the U.S. Plaintiffs are seeking transfer to the Southern District of Illinois.

Pradaxa was introduced by Boehringer Ingelheim in October 2010, as a superior alternative to Coumadin (warfarin) for prevention of stroke among patients with non-valvular atrial fibrillation. In December 2011, the U.S. Food & Drug Administration (FDA) released a safety communication warning patients of possible increased risk for bleeding events while taking Pradaxa. More recently, a report issued by the Institute for Safe Medication Practices reported that Pradaxa accounted for over 3000 serious adverse events in 2011, including over 500 patient deaths. [fda.gov/drugs/drugsafety/ucm282724.htm; ismp.org/quarterwatch/pdfs/2011Q4.pdf]

Watson Fentanyl Pain Patch Litigation (MDL 2372)

Watson Pharmaceutical is named in more than 20 complaints alleging that the company manufactured and sold defective fentanyl pain patches, which in some cases allowed fentanyl gel to leak directly onto the skin, leading to serious, and in some cases, fatal fentanyl overdoses. Plaintiffs have moved to have the litigation consolidated in the Northern District of Illinois.

Fentanyl is a highly addictive opiate that is 80 times more potent than morphine.[justice.gov/dea/concern/fentanyl.html] Fentanyl pain patches are used to provide around-the-clock, long-lasting relief to patients with moderate-to-severe chronic pain who have developed a tolerance to narcotic painkillers. The patches release fentanyl into the bloodstream through the skin, and can relieve pain for up to 72 hours. According to an FDA alert issued in April, there have been 26 cases of accidental exposure to fentanyl since 1997, most of them involving children younger than 2 years old. These reports included 10 deaths and 12 hospitalizations. [fda.gov/ForConsumers/ConsumerUpdates/ucm300803.htm?utm_campaign=Google2&utm_source=fdaSearch&utm_medium=website&utm_term=fentanyl%20patch&utm_content=1]

There is still time for victims of da Vinci Surgical robot, Pradaxa, and fentanyl pain patches who have suffered alleged injuries or side effects to file lawsuits in these pending litigations. To discuss a potential claim with one of the experienced and compassionate product liability lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website http://www.fightforvictims.com

About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.

For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com.

Contact:
Alonso Krangle LLP
445 Broad Hollow Road
Suite 205
Melville, New York 11747
Toll-FREE 1-800-403-6191
Tel: 516-350-5555
Fax: 516-350-5554

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Krangle

Andres Alonso
Visit website